UKRI CDT IN Biomedical AI w/ Julien Fauqueur
Join Julien Fauqueur, Lead AI Scientist of BenevolentAI, for a talk about how BenevolentAI combines AI with cutting edge science to de-risk drug discovery.
Mar 11, 2022
Please don’t use this sentence out of context
BenevolentAI and Stanford University review progress in their AI research partnership, which looks at the role of ​​co​​ntext in information extraction.
Feb 3, 2022
JP Morgan Healthcare Conference w/ Joanna Shields
Join our CEO, Joanna Shields at the 40th Annual J.P. Morgan Healthcare Conference on Monday, 10th January.
Jan 10, 2022
NeurIPS 2021 x LMLR Workshop w/ BenevolentAI Scientists
The BenevolentAI team return to NeurIPS 2021 to present two poster presentations at the LMLR workshop.
Dec 14, 2021
GPAI Paris w/ Joanna Shields
Our CEO Joanna Shields joins international AI experts from civil society, academia, industry and government at the Global Partnership on Artificial Intelligence (GPAI) Summit in Paris.
Nov 11, 2021
AI in Drug Discovery
This blog seeks to demystify the application of artificial intelligence (AI) and machine learning (ML) in drug discovery by exploring some of the challenges, opportunities and progress that has been achieved in the field so far.
Jul 13, 2021